CYP24A1 and neoplasm: The majority of compounds displayed potent inhibition and marked selectivity toward hCAs IX and XII, with compounds 170, 178, 180, and 183 emerging as the most selective toward the tumor-associated isoforms over the cytosolic hCA I and hCA II.